SCHEMBL27666161

SCHEMBL27666161

FC(F)(F)c1cccc(OC2CCN(c3cccc4ncc[c]c34)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SCN10A Q9Y5Y9 1/20 0.44
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
EPHX2 P34913 1/20 0.41
CNR1 P21554 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
SCD O00767 2/20 0.38
GAA P10253 1/20 0.38
CHRM4 P08173 1/20 0.37
HTR1A P08908 1/20 0.37
TRPA1 O75762 1/20 0.37
TRPV1 Q8NER1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27666033 0.85 CHRM4 (0.39) TP53MEN1KMT2ASCN10ASLC6A2
SCHEMBL28761513 0.81 CHRM4 (0.49) TP53MEN1KMT2ASCN10ASLC6A2
SCHEMBL2096022 0.76 ADRB2 (0.49) TP53MEN1KMT2ASCN10ASLC6A2
SCHEMBL2096017 0.76 ADRB2 (0.49) TP53MEN1KMT2ASCN10ASLC6A2
SCHEMBL27644493 0.74 TP53 (0.46) TP53MEN1KMT2ASCN10ASLC6A2
SCHEMBL27665945 0.73 EPHX2 (0.38) EPHX2CHRM4
SCHEMBL20858622 0.71 SLC6A2 (0.69) TP53MEN1KMT2ASLC6A2SLC6A4
SCHEMBL2090360 0.71 SCN10A (0.41) TP53MEN1KMT2ASCN10ASLC6A2
SCHEMBL2090364 0.71 SCN10A (0.41) TP53MEN1KMT2ASCN10ASLC6A2
SCHEMBL5544454 0.71 TP53 (0.59) TP53MEN1KMT2ASCN10ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed